NASDAQ:EXEL is an undervalued gem with solid fundamentals.

Last update: Nov 8, 2024

EXELIXIS INC (NASDAQ:EXEL) is a hidden gem identified by our stock screening tool, featuring undervaluation and robust fundamentals. NASDAQ:EXEL showcases decent financial health and profitability, coupled with an attractive price. Let's dig deeper into the analysis.

Valuation Analysis for NASDAQ:EXEL

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:EXEL has earned a 8 for valuation:

Based on the Price/Earnings ratio, EXEL is valued cheaper than 96.26% of the companies in the same industry.
EXEL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.94.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXEL indicates a rather cheap valuation: EXEL is cheaper than 94.83% of the companies listed in the same industry.
96.97% of the companies in the same industry are more expensive than EXEL, based on the Enterprise Value to EBITDA ratio.
96.61% of the companies in the same industry are more expensive than EXEL, based on the Price/Free Cash Flow ratio.
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXEL has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EXEL's earnings are expected to grow with 50.37% in the coming years.

What does the Profitability looks like for NASDAQ:EXEL

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:EXEL has achieved a 8:

With an excellent Return On Assets value of 15.77%, EXEL belongs to the best of the industry, outperforming 98.22% of the companies in the same industry.
EXEL has a better Return On Equity (20.52%) than 97.50% of its industry peers.
The Return On Invested Capital of EXEL (18.78%) is better than 97.68% of its industry peers.
The last Return On Invested Capital (18.78%) for EXEL is above the 3 year average (7.03%), which is a sign of increasing profitability.
EXEL has a better Profit Margin (22.43%) than 97.15% of its industry peers.
EXEL has a better Operating Margin (29.22%) than 98.22% of its industry peers.
EXEL's Gross Margin of 96.25% is amongst the best of the industry. EXEL outperforms 96.61% of its industry peers.

Health Analysis for NASDAQ:EXEL

ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NASDAQ:EXEL, the assigned 8 reflects its health status:

An Altman-Z score of 10.76 indicates that EXEL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.76, EXEL belongs to the top of the industry, outperforming 85.20% of the companies in the same industry.
EXEL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
A Current Ratio of 3.93 indicates that EXEL has no problem at all paying its short term obligations.
EXEL has a Quick Ratio of 3.88. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.

Growth Assessment of NASDAQ:EXEL

ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:EXEL, the assigned 6 reflects its growth potential:

EXEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 510.71%, which is quite impressive.
EXEL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.31%.
The Revenue has been growing by 16.47% on average over the past years. This is quite good.
The Earnings Per Share is expected to grow by 35.45% on average over the next years. This is a very strong growth
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

More Decent Value stocks can be found in our Decent Value screener.

For an up to date full fundamental analysis you can check the fundamental report of EXEL

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.